Slide of the Month
WHERE TO MEET US
Attendance at upcoming meetings and conferences
Our most recent publications
R&D Briefing 61: Building quality into decision-making processes in medicines’ development, regulatory review and health technology assessment
R&D Briefing 60: Early scientific advice from HTA agencies: How does the effective use of the various kinds of advice support a positive HTA recommendation?
R&D Briefing 59: The impact of the evolving regulatory environment on the approval of new medicines across six major authorities 2006-2015
Abstract: Liberti L, Breckenridge A, Hoekman J, Leufkens H, Lumpkin M, McAuslane N, Stolk P, Zhi K, Rägo L. Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities. J Public Health Policy. 2016 Mar 10. doi: 10.1057/jphp.2016.8. [Epub ahead of print]